Vanguard Fiduciary Trust’s ENDRA Life Sciences NDRA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio NDRA Stock Details NDRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.9K	Hold	10,121	–	–	﹤0.01%	3850
2026 Q1	$47.1K	Buy	+10,121	New	+$40.1K	﹤0.01%	3836

Other funds holding NDRA

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Vanguard Fiduciary Trust's NDRA Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its ENDRA Life Sciences (NDRA) position steady in Q2 2026 at 10,121 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3850.

Vanguard Fiduciary Trust first reported a position in NDRA in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold NDRA as of Q2 2026.

Vanguard Fiduciary Trust held 10,121 shares of ENDRA Life Sciences worth $53.9K as of Q2 2026.
Vanguard Fiduciary Trust left its ENDRA Life Sciences share count unchanged in Q2 2026.
ENDRA Life Sciences made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3850 holding.
Vanguard Fiduciary Trust first reported a position in ENDRA Life Sciences in Q1 2026 and has held it in 2 quarters since.
9 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.